{"nct_id":"NCT06960395","title":"Safety and Preliminary Efficacy of VIR-5525 and VIR-5525 + Pembrolizumab in Participants With Locally Advanced or Metastatic Solid Tumors","status":"RECRUITING","status_verified_date":"2025-07","start_date":"2025-07-22","start_date_type":"ACTUAL","primary_completion_date":"2029-08","primary_completion_date_type":"ESTIMATED","completion_date":"2029-08","completion_date_type":"ESTIMATED","phases":["PHASE1"],"tickers":["VIR"]}